| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIOTIME INC | 20,084 | 12,000 | 0.00% | ||
| 2 | CYCLACEL PHARMACEUTICALS INC | 13,253 | 83,000 | 0.00% | ||
| 3 | BioPharmX Corporation | 377,295 | 191,000 | 0.00% | ||
| 4 | WINDTREE THERAPEUTICS INC | 254,973 | 291,000 | 0.00% | ||
| 5 | CHEMOCENTRYX INC | 49,064 | 357,000 | 0.00% | ||
| 6 | BIODELIVERY SCIENCES INTL IN | 210,021 | 399,000 | 0.00% | ||
| 7 | DYNAVAX TECHNOLOGIES CORP | 75,000 | 446,000 | 0.00% | ||
| 8 | BIOVERATIV INC | 8,249 | 449,000 | 0.00% | ||
| 9 | Proteon Therapeutics Inc | 298,591 | 523,000 | 0.00% | ||
| 10 | ADAPTIMMUNE THERAPEUTICS PLC | 100,000 | 551,000 | 0.00% | ||
| 11 | RITTER PHARMACEUTICALS INC | 400,000 | 568,000 | 0.00% | ||
| 12 | ARBUTUS BIOPHARMA CORP | 180,582 | 587,000 | 0.00% | ||
| 13 | PALATIN TECHNOLOGIES INC COM | 2,050,000 | 671,000 | 0.01% | ||
| 14 | FIVE PRIME THERAPEUTICS INC | 19,247 | 696,000 | 0.01% | ||
| 15 | CHIMERIX INC | 115,216 | 735,000 | 0.01% | ||
| 16 | ACCELERON PHARMA INC | 28,765 | 761,000 | 0.01% | ||
| 17 | MADRIGAL PHARMACEUTICALS INC | 57,762 | 890,000 | 0.01% | ||
| 18 | AFFIMED N V COM | 400,000 | 920,000 | 0.01% | ||
| 19 | IMMUNE DESIGN CORP | 148,937 | 1,013,000 | 0.01% | ||
| 20 | CORBUS PHARMACEUTICALS HLDGS | 130,129 | 1,074,000 | 0.01% | ||
| 21 | JUNO THERAPEUTICS INC COM | 50,000 | 1,110,000 | 0.01% | ||
| 22 | CELLECTIS S A | 50,000 | 1,200,000 | 0.01% | ||
| 23 | MYOKARDIA INC | 100,000 | 1,315,000 | 0.01% | ||
| 24 | FULGENT GENETICS INC | 125,000 | 1,365,000 | 0.01% | ||
| 25 | SERES THERAPEUTICS INC | 125,000 | 1,409,000 | 0.01% | ||
| 26 | AEGLEA BIOTHERAPEUTICS INC | 189,987 | 1,415,000 | 0.01% | ||
| 27 | MEDIWOUND ORD | 226,000 | 1,492,000 | 0.01% | ||
| 28 | INVIVO THERAPEUTICS HLDGS CORPORATION COM NEW | 400,000 | 1,620,000 | 0.01% | ||
| 29 | INFINITY PHARMACEUTICALS INC | 580,400 | 1,875,000 | 0.02% | ||
| 30 | Spring Bank Pharmaceuticals In | 219,298 | 1,952,000 | 0.02% | ||
| 31 | Natera, Inc. | 228,676 | 2,028,000 | 0.02% | ||
| 32 | GLYCOMIMETICS INC | 381,235 | 2,070,000 | 0.02% | ||
| 33 | TONIX PHARMACEUTICALS HLDG C | 449,500 | 2,099,000 | 0.02% | ||
| 34 | DIMENSION THERAPEUTICS INC | 1,251,881 | 2,191,000 | 0.02% | ||
| 35 | JOUNCE THERAPEUTICS INC | 100,000 | 2,199,000 | 0.02% | ||
| 36 | SELECTA BIOSCIENCES INC | 175,712 | 2,516,000 | 0.02% | ||
| 37 | PROTALIX BIOTHERAPEUTICS INC | 3,423,000 | 2,543,000 | 0.02% | PRN | |
| 38 | TRILLIUM THERAPEUTICS INC | 413,697 | 2,544,000 | 0.02% | ||
| 39 | KARYOPHARM THERAPEUTICS INC COM | 216,990 | 2,786,000 | 0.02% | ||
| 40 | INOTEK PHARMACEUTICALS CORP | 5,000,000 | 3,008,000 | 0.02% | PRN | |
| 41 | Aevi Genomic Medicine Inc | 1,618,089 | 3,010,000 | 0.02% | ||
| 42 | ADAMAS PHARMACEUTICALS INC | 172,630 | 3,021,000 | 0.02% | ||
| 43 | Sunesis Pharmaceuticals, Inc. | 741,665 | 3,041,000 | 0.02% | ||
| 44 | TREVENA INC | 857,206 | 3,146,000 | 0.03% | ||
| 45 | SYROS PHARMACEUTICALS INC | 204,465 | 3,257,000 | 0.03% | ||
| 46 | ULTRAGENYX PHARMACEUTICAL INC COM | 50,000 | 3,389,000 | 0.03% | ||
| 47 | RA PHARMACEUTICALS INC COM | 177,952 | 3,789,000 | 0.03% | ||
| 48 | EPIZYME INC COM | 232,481 | 3,987,000 | 0.03% | ||
| 49 | ZOGENIX INC | 381,939 | 4,144,000 | 0.03% | ||
| 50 | ANAPTYSBIO INC | 150,000 | 4,163,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-17-027430, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
